U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C15H10F7N3O2S2
Molecular Weight 461.378
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SAVIPRAZOLE

SMILES

[O-][S+](CC1=CC(OCC(F)(F)C(F)(F)C(F)(F)F)=CC=N1)C2=NC3=CSC=C3N2

InChI

InChIKey=ARFGGIRJBPTBPP-UHFFFAOYSA-N
InChI=1S/C15H10F7N3O2S2/c16-13(17,14(18,19)15(20,21)22)7-27-9-1-2-23-8(3-9)6-29(26)12-24-10-4-28-5-11(10)25-12/h1-5H,6-7H2,(H,24,25)

HIDE SMILES / InChI

Molecular Formula C15H10F7N3O2S2
Molecular Weight 461.378
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Saviprazole (also known as HOE 731) is a potent inhibitor of gastric H+/K(+)-ATPase that has been studied in phase I clinical trial for the treatment of gastric ulcer. However, this study was discontinued.

Originator

Approval Year

PubMed

Substance Class Chemical
Record UNII
8NO3IX3KJ7
Record Status Validated (UNII)
Record Version